On the intravenous tolbutamide test (ivTT) in patients with coronary disease. (Glucide-lipid metabolic relationships)
Popescu, P.; Anghel, S.; Idu, S.; Mihai, N.; Moldovan, T.; Mihail, A.
Medicina Interna 26(4): 445-452
1974
ISSN/ISBN: 0025-7869 PMID: 4839351 Document Number: 77288
Document emailed within 1 workday
Related Documents
Schwartzkopff, W.; Zschiedrich, M.; Gründler, G.; Schlicht, E. 1976: Determination of lipid and lipoprotein kinetics by means of the intravenous lipid tolerance test in patients with portacaval shunt Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 850-854Khuangsirikul, W.; Jalayondeja, W.; Chuanchaiyakul, R.; Krittayaphong, R.; Chotinaiwattarakul, C.; Laksanabunsong, P. 2014: Metabolic equivalent of exercise stress test explained by six-minute walk test in post coronary artery bypass graft and post percutaneous coronary intervention patients Journal of the Medical Association of Thailand 97(Suppl 7): S6-S9
Kalyuzhin, V.V.; Teplyakov, A.T.; Pushnikova, E.Y.; Bespalova, L.D.; Kalyuzhina, E.V.; Kolesnikov, R.N. 2013: Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome Terapevticheskii Arkhiv 85(5): 68-72
Beleites, H.; Fröhlich, F.; Baunach, E. 1970: A technical set-up for the quick evaluation of the intravenous tolbutamide test in the diagnosis of diabetes mellitus Zeitschrift für Medizinische Labortechnik 11(2): 98-101
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19
Kravchun, P.; Kadykova, O.; Gabisoniia, T. 2012: The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease Georgian Medical News 213: 26-31
Kovacs, I.B.; Jahangiri, M.; Ridler, C.D.; Görög, P.; Rees, G.M. 1998: Thrombogenic and atherogenic lipid modifications in plasma and patients with coronary artery disease and after coronary artery bypass surgery Rinsho Byori. Japanese Journal of Clinical Pathology 46(7): 656-662
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Manfredini, R.; Finzi, A.; Bertoni, T.; Lamarchesina, U.; Nador, F.; Lotto, A. 1994: Combination of transesophageal atrial pacing and echo-dipyridamole test in the diagnosis of coronary disease in patients with suspected angina pectoris and negative exercise test Giornale Italiano di Cardiologia 24(11): 1379-1386
Ianovskiĭ, G.V.; Solovtsova, K.M. 1979: Physical load tolerance and lipid metabolic indices in patients with the initial manifestations of ischemic heart disease Kardiologiia 19(9): 74-78
Puri, A.; Gupta, O.K.; Dwivedi, R.N.; Bharadwaj, R.P.S.; Narain, V.S.; Singh, S. 2003: Homocysteine and lipid levels in young patients with coronary artery disease Journal of the Association of Physicians of India 51: 681-685
Janssen, K. 2000: Lipid profile in 4 minutes. Impressing your coronary heart disease patients MMW Fortschritte der Medizin 142(26-27): 39
Supanich, B. 1999: Aggressive lipid-lowering in stable patients with coronary artery disease Journal of Family Practice 48(10): 749-750
Denisova, T.P.; Malinov, I.A. 1999: The functional interrelationships of blood glucose and immunoreactive insulin in the intravenous glucose tolerance test in coronary atherosclerosis patients Klinicheskaia Laboratornaia Diagnostika 7: 9-11
Medvedeva, I.V.; Dorodneva, E.F.; Pugacheva, T.A.; Belokorylova, L.V.; Shorokhova, T.D.; Ushakova, M.A. 2002: Analysis of lipid plasma spectrum and basic parameters of red cell membranes in patients with metabolic syndrome and ischemic heart disease Klinicheskaia Meditsina 80(5): 27-30
Souza, D.R.S.; Nakachima, L.; Biagioni, R.B.; Nakazone, M.A.; Pinhel, M.A.S.; Trindade, D.M.; Mafra, V.T.; Tácito, L.H.B.; Martin, J.F.V.; Pinheiro Júnior, S.; Brandão, A.C. 2007: Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease Brazilian Journal of Medical and Biological Research 40(2): 189-197
Gulati, S.; Saxena, A. 2003: Study of lipid profile in children of patients with premature coronary artery disease Indian Pediatrics 40(6): 556-560
Panina, E.B.; Botvinnik, V.S. 1992: The role of autonomic dysfunction in the pathogenesis of lipid and lipoprotein metabolic disorders in patients with metabolic-alimentary obesity Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(5-12): 22-24
Müting, D.; Dohn, P.; Reikowski, J. 1972: Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1389-1392